我国成人肥胖超过50％！柳叶刀揭示目前最有效减肥方式！( 四 )

综上，我国肥胖问题日益严峻，饮食结构的调整、久坐而缺乏运动的生活方式、日益增加的生活工作压力等都在有形或无形中为我们的身体增添了“负担” 。好在随着医药科学技术的发展，新型减肥药物加上安全可靠的减肥手术有望为更多人改善整体健康状态、降低长期死亡率、延长预期寿命。
最后，虽然官方未认定肥胖为疾病，但肥胖是病，确实得治！治愈肥胖指日可待！
参考文献：
1. 薛伟. 《中国居民营养与慢性病状况报告（2020年）》：我国超过一半成年居民超重或肥胖 [J] . 中华医学信息导报, 2020, 35(24): 15-15. DOI: 10.3760/cma.j.issn.1000-8039.2020.24.125.
2. Pan XF, et al. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021 Jun;9(6):373-392. doi: 10.1016/S2213-8587(21)00045-0.
3. Locke AE, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015 Feb 12;518(7538):197-206. doi: 10.1038/nature14177.
4. Renehan AG, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008 Feb 16;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X.
5. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989. doi: 10.1056/NEJMoa2032183.
6. Wadden TA, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021 Apr 13;325(14):1403-1413. doi: 10.1001/jama.2021.1831.
7. Syn NL, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174772 participants. Lancet. 2021 May 15;397(10287):1830-1841. doi: 10.1016/S0140-6736(21)00591-2.
撰文 | Dr.Neuro
编辑 | Jessica
授权转载及爆料请联络梅斯医学管理员